Phase 4 Type 2 Diabetes Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- Men or women who are not currently pregnant
- Adults between the ages of 18 and 65 (inclusive)
- People who are willing and able to give their informed consent to participate
- People whose blood sugar levels fall in a specific range — between normal and pre-diabetes — based on a fasting glucose reading of 100–125 mg/dL from existing lab records
Who may not be able to join:
- People who are currently taking, or planning to take, medications to treat diabetes
- People who are currently taking, or planning to take, medications known to affect blood sugar levels, such as steroids (glucocorticoids), growth hormone, or certain antibiotics called fluoroquinolones
- People with a personal history of poor nutrient absorption by the intestines, weight-loss (bariatric) surgery, celiac disease, gallbladder disease, or pancreatitis (inflammation of the pancreas)
- People with a personal or family history of a specific thyroid cancer (medullary thyroid cancer) or a condition called multiple endocrine neoplasia type 2
- People whose kidneys are not functioning above a certain level, based on a specific blood test result (confirm with trial site)
- People with a history of liver scarring (cirrhosis) or certain abnormal liver enzyme levels on blood tests
- People who have dietary restrictions that would prevent them from consuming a specific test meal used in the study (confirm with trial site)
- Women who are pregnant, breastfeeding, or at risk of becoming pregnant
- People who are already taking part in another interventional research study at the same time
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Josephine Li, MD, MGH
Phone: 6176435419
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Insulin response to oral semaglutide treatment
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.